StreetAlpha
PharmaCyte Biotech, Inc. · SEC Form 4

PMCB Insider Trading

From SEC Form 42 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of PharmaCyte Biotech, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are buying over the last 12 months: $129K bought and $0 sold.

← PMCB stock page

Insiders are buying
Bought, 12 months$129K2 buys · 2 insiders
Sold, 12 months$00 sales · 0 insiders
Net+$129Kbought minus sold
Planned sales–of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
Dec2026-01: bought $129KJanFebMarAprMayJunJulAugSepOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when PMCB insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an PMCB officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

PMCB cluster buys

All PMCB cluster buys →
  • 2 insiders bought $129KTrades Jan 5, 2026 to Jan 7, 2026 · public Jan 7, 2026

A cluster buy is two or more insiders buying on the open market within 30 days of each other.

Every PMCB insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Jan 7, 2026Jonathan SchechterDirectorBuy60,000$0.80$48K192,500Jan 7Form 4
Jan 7, 2026Joshua SilvermanCEO and PresidentBuy100,000$0.80$80K416,250Jan 7Form 4

PMCB insider trading FAQ

Are PMCB insiders buying or selling?

Insiders are buying over the last 12 months. 2 insiders bought $129K of PMCB on the open market in 2 trades, and 0 sold $0 in 0 trades.

When did an PMCB insider last buy shares?

Jonathan Schechter (Director) bought 60,000 shares for $48K on Jan 7, 2026, reported on Jan 7, 2026.

When did an PMCB insider last sell shares?

There has been no open market insider sale of PMCB in the last two years.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice